Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

OTHER 7 NIH 5 INDUSTRY 3 OTHER_GOV 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 22 Prostatic Neoplasms 18 Carcinoma, Non-Small-Cell Lung 17 Precursor Cell Lymphoblastic Leukemia-Lymphoma 14 Multiple Myeloma 14 Lymphoma 12 Colorectal Neoplasms 12 Neoplasms 9 Melanoma 9 Lung Neoplasms 8 Leukemia, Myeloid, Acute 8 Pancreatic Neoplasms 7 Lymphoma, Non-Hodgkin 7 Wilms Tumor 6 Leukemia, Biphenotypic, Acute 6 HIV Infections 6 Burkitt Lymphoma 6 Squamous Cell Carcinoma of Head and Neck 5 Lymphoma, Mantle-Cell 5 Hematologic Neoplasms 5 Head and Neck Neoplasms 5 Ependymoma 5 Colonic Neoplasms 5 Rectal Neoplasms 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 4 Ovarian Neoplasms 4 Osteosarcoma 4 Medulloblastoma 4 Malignant Solid Neoplasm 4

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Thymoma × 90 days × Clear all

NCT03134118 2026-05-15

NIVOTHYM

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Active not recruiting

Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡